דסטיניב תרו 100 מ"ג - Dasatinib taro 100 mg

× ×ª×× × ×ª×¨××¤×

×××¨×©×

××× ×× ×× × ××¡×¤××	××¡××× ×× ××¡.×§×× 100 ×"× - Dasatinib s.k. 100 mg ××¡××× ×× ××¡.×§×× 140 ×"× - Dasatinib s.k. 140 mg ××¡××× ×× ××¡.×§×× 20 ×"× - Dasatinib s.k. 20 mg ××¡××× ×× ××¡.×§×× 50 ×"× - Dasatinib s.k. 50 mg ××¡××× ×× ××¡.×§×× 70 ×"× - Dasatinib s.k. 70 mg ××¡××× ×× ×¡× ××× 100 ×"× - Dasatinib sandoz 100 mg ××¡××× ×× ×¡× ××× 140 ×"× - Dasatinib sandoz 140 mg ××¡××× ×× ×¡× ××× 20 ×"× - Dasatinib sandoz 20 mg ××¡××× ×× ×¡× ××× 50 ×"× - Dasatinib sandoz 50 mg ××¡××× ×× ×¡× ××× 70 ×"× - Dasatinib sandoz 70 mg â¦ ×ª××¦×××ª × ××¡×¤××ª
×§×××¦× ×¤×¨××§××××××ª (ATC4)	L01EA BCR-ABL tyrosine kinase inhibitors
××¨××× ×¤×¢×× (ATC5)	Â Dasatinib 100 MG âL01EA02
×¦××¨×ª ××ª×	×¤××× - PER OS
×¦××¨×ª ××× ××	××××××ª ××¦××¤××ª ×¤×××, FILM COATED TABLETS ××× ××¢×ª ××× ×× ××ª×¨ ×× ××¨×¢×× ××© ××××× ××ª ××ª×¨××¤× ×××ª×× ×××× ×× ××××××¥ ××¤× ×©×××¤××¢ ××¢××× ××¦×¨××
××ª××××	Dasatinib Taro is indicated for the treatment of adult patients with: * Newly diagnosed Philadelphia chromosome positive (Ph+) chronic myelogenous leukaemia (CML) in the chronic phase. * Chronic, accelerated or blast phase CML with resistance or intolerance to prior therapy including imatinib mesilate. * Ph+ acute lymphoblastic leukaemia (ALL) and lymphoid blast CML with resistance or intolerance to prior therapy.
×¢××× ××¨××¤× ×××××¨××ª ××¢×××	××× ×¢××× ××¨××¤× Â

×¢××× ××¦×¨××	Â

×¢×¨××× ×××××§××¨×¤×××	×¢×¨××× ×§×©××¨×× ×××××§××¨×¤×××
××¡××× ×× ×ª×¨× 100 ×"× ×××××¨ ××©×¨× ×××¨××××ª

×××¤××© ××××¨××	××××¨×× ×-PubMed
××××¢ ××¨×©×ª	RxList WebMD Drugs.com
×©× ××¦×¨×	SYNTHON HISPANIA S.L., SPAIN
×©× ××¢× ××¨××©××	TARO INTERNATIONAL LTD, ISRAEL
×¨××©×××	×ª××¨×× ×××©×: 1/2020. ×¨××©××× ××ª××¨××:
×ª××¨×× ×¢×××× ×××¨××	04/01/2022

השינוי האחרון נעשה בֹ־1 ביולי 2025 ב־05:20